NCT07838558 Comparative Effects of Autogenic Inhibition vs Reciprocal Inhibition in Patients With Lower Cross Syndrome
| NCT ID | NCT07838558 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Lower Cross Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 46 participants |
| Start Date | 2026-02-12 |
| Primary Completion | 2026-12-18 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 46 participants in total. It began in 2026-02-12 with a primary completion date of 2026-12-18.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial aims to compare the effectiveness of Autogenic Inhibition Muscle Energy Technique (MET) and Reciprocal Inhibition MET in individuals with Lower Crossed Syndrome. Participants will be randomly assigned to two intervention groups. One group will receive Autogenic Inhibition MET, while the other will receive Reciprocal Inhibition MET for the iliopsoas, rectus femoris, and erector spinae muscles. Both groups will also perform the same standardized strengthening exercises targeting the transversus abdominis, gluteus maximus, and gluteus medius muscles to improve muscle balance and functional outcomes.
Eligibility Criteria
Inclusion Criteria * Age 19-35 years. * Both genders will include in this study. * According to Janda's Approach, Clinical diagnosis of LCS based on ≥3 positive clinical tests. * Patient with positive modified Thomas test, Patients with a positive testing of prone hip extension test, Patients with a positive test of trunk flexion test, Patients with tight erector spinae muscles. * Participants with no lumbar pain to moderate lumbar pain (NPRS0-6) will be included. * Painless movement and activity. * Pain only produced by sustained loading in relevant position, which is then relieved after maintaining a corrected posture for 5 minutes, indicating posture-related pain. Exclusion Criteria * Leg symptoms when walking, eased in flexion (Signs of stenosis) * Pain due to repetitive movement * Lumbar Radiculopathy * Neurological Symptoms (Paresthesia/numbness) * Structural deformity (Kyphosis, lordosis, scoliosis, spondylosis, spondylolysis, spondylolisthesis)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07838558 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 35 Years, studying Lower Cross Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07838558 currently recruiting?
Yes, NCT07838558 is actively recruiting participants. Contact the research team at momnakhadim117@gmail.com for enrollment information.
Where is the NCT07838558 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07838558 clinical trial?
NCT07838558 is sponsored by Foundation University Islamabad. The trial plans to enroll 46 participants.